Arcturus Therapeutics Holdings ARCT
NASDAQ ARCT
$13.03 -0.18 (-1.36%)
At close: Oct 2, 2026 · 4:00 PM EDT

Arcturus Therapeutics Holdings (ARCT) Cash & Current Investments (2018 - 2026)

Updated

Arcturus Therapeutics Holdings (ARCT) posted Cash & Current Investments of $191.48 million for Q2 2026, down 2.5% from $196.47 million a year earlier and down 9.4% from the prior quarter.

Analysis

Arcturus Therapeutics Holdings (ARCT) Cash & Current Investments (2018 - 2026) Analysis & Trends

At the end of FY2025, Arcturus Therapeutics Holdings' Cash & Current Investments came in at $230.91 million, down 21.4% from FY2024.

  • Annual Cash & Current Investments shows a five-year compound annual growth rate of -13.0% (FY2020 to FY2025).
  • In prior years, Arcturus Therapeutics Holdings' Cash & Current Investments was $293.91 million in FY2024 (+0.7%), $292.01 million in FY2023 (-25.5%), $391.88 million in FY2022 (+5.8%) and $370.49 million in FY2021 (-20.0%).
  • Quarterly Cash & Current Investments has run from a low of $180.36 million in Q3 2025 to a high of $413.88 million in Q3 2021 over five years.
  • On a year-over-year basis, Cash & Current Investments has declined in each of the last six quarters, with an average decline of 15.4% over the last eight quarters.
  • The strongest year-over-year quarter for Cash & Current Investments in the past five years was Q3 2021, with growth of 34.8%; the weakest was Q3 2022, with a decline of 42.6%.
  • According to Business Quant data, Cash & Current Investments for the three prior quarters was $211.38 million (Q1 2026), $230.91 million (Q4 2025) and $180.36 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn 20.76 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn 6.57 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn 9.92 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn 4.97 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn 3.18 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 11.70 Bn
10 Arcturus Therapeutics Holdings 370.35 Mn -443.78 Mn - 191.48 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 191.48 Mn
Mar 31, 2026 211.38 Mn
Dec 31, 2025 230.91 Mn
Sep 30, 2025 180.36 Mn
Jun 30, 2025 196.47 Mn
Mar 31, 2025 216.95 Mn
Dec 31, 2024 293.91 Mn
Sep 30, 2024 237.18 Mn
Jun 30, 2024 260.33 Mn
Mar 31, 2024 288.40 Mn
Dec 31, 2023 292.01 Mn
Sep 30, 2023 311.92 Mn
Jun 30, 2023 323.47 Mn
Mar 31, 2023 327.94 Mn
Dec 31, 2022 391.88 Mn
Sep 30, 2022 237.68 Mn
Jun 30, 2022 283.49 Mn
Mar 31, 2022 319.68 Mn
Dec 31, 2021 370.49 Mn
Sep 30, 2021 413.88 Mn
API Access

Arcturus Therapeutics Holdings Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=ARCT&period=max&api_key=YOUR_API_KEY